Hospital Pharmacists’ Intervention In Access To InnovativeTherapies – Opportunities And Strategies: A Mixed-MethodDesign
Main Article Content
Keywords
Hospital Pharmaceutical Service, Innovative therapies
Abstract
Aim: Hospital Pharmacists play a crucial role in various activities within hospitals to ensure patient access to innovative therapies, particularly in the decision-making process. Their involvement spans from evaluating new therapies to ensuring compliance with legal and regulatory frameworks. However, the complexity of this process presents challenges that can delay patient access to necessary treatments. This study aims to evaluate the contribution of Hospital Pharmacists in the innovation pathway and to identify opportunities and strategies that enhance Hospital Pharmacists ‘ intervention in improving the access to innovative therapies. By understanding these opportunities, we can develop actionable strategies to optimize the role of Hospital Pharmacists, ensuring more timely and efficient patient access to therapeutic innovations. Methods: A mixed-method approach was employed, beginning with semi- structured interviews to gather in-depth insights from Hospital Pharmacists. Following this qualitative phase, a survey was conducted among Portuguese Hospital Pharmacists to quantify their experiences and perceptions, receiving 58 responses. The study culminated in an expert panel discussion, comprising 12 experienced Hospital Pharmacists, to reach a consensus on strategic actions. Data collection occurred between October 2021 and March 2022. Results: The survey revealed that, although Hospital Pharmacists are heavily involved in supporting decision-making for the approval of innovative therapies, there are significant opportunities to optimize this process. The expert panel identified and proposed five strategic actions aimed at improving access to legal information about innovative therapies, streamlining the approval process, and fostering collaboration among stakeholders, including regulatory bodies, healthcare providers, and pharmaceutical companies. Conclusion: The intervention of Hospital Pharmacists in the decision-making process is critical to the access pathway for innovative therapies. Implementing the identified strategies could enhance the efficiency, speed, and effectiveness of this process, ultimately benefiting patient care by ensuring quicker access to cutting-edge treatments.
References
2. Barua B, Westcott W, Vo VN. Timely Access to New Pharmaceuticals in Canada, the United States, and the European Union [Internet]. 2021 [cited 2023 Aug 11].
3. Medlinskiene K, Tomlinson J, Marques I, et al. Barriers and facilitators to the uptake of new medicines into clinical practice: a systematic review. BMC Health Serv Res. 2021 Dec 1;21(1).
4. Ciccarello C, Leber MB, Leonard MC, et al. ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System. Am J Health Syst Pharm. 2021 May 15;78(10):907–18.
5. J Manag Care Spec Pharm. AMCP Partnership Forum: Principles for Sound Pharmacy and Therapeutics (P&T) Committee Practices: What’s Next? J Manag Care Spec Pharm [Internet]. 2020;26. Available from: www.jmcp.org
6. Hoffmann M. The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees. Eur J Clin Pharmacol [Internet]. 2013 May 3;69(S1):79–87.
7. Seyoum H, Feleke Z, Bikila D, Yaregal A, Demisie A, Ali S, et al. Drug and Therapeutics Committee (DTC) evolvement and expanded scope in Ethiopia. Gates Open Res [Internet]. 2023 Mar 10;5:70.
8. Shulkin D. Reinventing the pharmacy and therapeutics committee. Pharm Ther [Internet]. 2012 Nov;37(11):623–4. Available from: www.ashp.org.
9. Pedersen CA, Schneider PJ, Ganio MC, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: Dispensing and administration. Am J Health Syst Pharm. 2020 Jun 15;78(12):1074–93.
10. Frontini R, Frontini R. The European summit on hospital pharmacy. Eur J Hosp Pharm. 2014 Oct 1;21(5):255.
11. Ministério da Saúde. Despacho n.o 2325/2017 [Internet]. Portugal; 2017 [cited 2023 Jul 18].
12. Gomes J, Gonçalves J, Barros V, et al. Estudo valorização do desempenho do Farmacêutico Hospitalar [Internet]. 2021 [cited 2023 Jul 17].
13. Anell A, Svarvar P. Pharmacoeconomics and Clinical Practice Guidelines. A Survey of Attitudes in Swedish Formulary Committees. Pharmacoeconomics. 2000;17(2):175–85.
14. Bagozzi RP, Ascione FJ, Mannebach MA. Inter-role relationships in hospital-based pharmacy and therapeutics committee decision making. J Health Psychol. 2005 Jan;10(1):45–64.
15. Ordem dos Farmacêuticos. Farmacêuticos em Números [Internet]. 2022 [cited 2023 Aug 11].
16. World Health Organization and World Bank Group. (2017). Healthy systems for universal health coverage-a joint vision for healthy lives (UHC2030).
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.